These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32471010)

  • 1. Healthcare utilization and direct medical cost in the years during and after cancer diagnosis in patients with type 2 diabetes mellitus.
    Wu T; Yang F; Chan WWL; Lam CLK; Wong CKH
    J Diabetes Investig; 2020 Nov; 11(6):1661-1672. PubMed ID: 32471010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct medical costs in the preceding, event and subsequent years of a first severe hypoglycaemia episode requiring hospitalization: A population-based cohort study.
    Wong CKH; Tong T; Cheng GHL; Tang EHM; Thokala P; Tse ETY; Lam CLK
    Diabetes Obes Metab; 2019 Jun; 21(6):1330-1339. PubMed ID: 30737873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct medical costs of diabetes mellitus in the year of mortality and year preceding the year of mortality.
    Wong CKH; Jiao F; Tang EHM; Tong T; Thokala P; Lam CLK
    Diabetes Obes Metab; 2018 Jun; 20(6):1470-1478. PubMed ID: 29430799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.
    Kalsekar I; Iyer S; Mody R; Rajagopalan R; Kavookjian J
    J Manag Care Pharm; 2006 Mar; 12(2):121-9. PubMed ID: 16515370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of healthcare resource utilization and costs in patients with type 2 diabetes initiating dapagliflozin versus sitagliptin.
    Parker ED; Wittbrodt ET; McPheeters JT; Frias JP
    Diabetes Obes Metab; 2019 Feb; 21(2):227-233. PubMed ID: 30101553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic burden of breakthrough seizures.
    Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis.
    Kong AM; Farahbakhshian S; Pendergraft T; Brouillette MA; Mukherjee B; Smith DM; Sheehan JJ
    Curr Med Res Opin; 2017 Oct; 33(10):1869-1877. PubMed ID: 28613952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort.
    Chen HL; Hsu WW; Hsiao FY
    J Diabetes Complications; 2015; 29(4):523-8. PubMed ID: 25770886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States.
    Jain R; Fu AC; Lim J; Wang C; Elder J; Sander SD; Tan H
    J Manag Care Spec Pharm; 2018 Jan; 24(1):73-82. PubMed ID: 29290177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis.
    Cheng SW; Wang CY; Chen JH; Ko Y
    Medicine (Baltimore); 2018 Aug; 97(31):e11602. PubMed ID: 30075532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases.
    Fuldeore M; Yang H; Du EX; Soliman AM; Wu EQ; Winkel C
    Fertil Steril; 2015 Jan; 103(1):163-71. PubMed ID: 25455535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is hypoglycemia expensive in China?
    Lan K; Wang J; Nicholas S; Tang Q; Chang A; Xu J
    Medicine (Baltimore); 2021 Feb; 100(5):e24067. PubMed ID: 33592860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Care Resource Utilization and Cost Before Initial Schizophrenia Diagnosis.
    Wallace A; Barron J; York W; Isenberg K; Franchino-Elder J; Sidovar M; Sand M
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1102-1110. PubMed ID: 31556820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
    Gandra SR; Lawrence LW; Parasuraman BM; Darin RM; Sherman JJ; Wall JL
    J Manag Care Pharm; 2006 Sep; 12(7):546-54. PubMed ID: 16981800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.
    Sato M; Ye W; Sugihara T; Isaka Y
    BMC Musculoskelet Disord; 2016 Nov; 17(1):489. PubMed ID: 27887655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in Israel.
    Melzer Cohen C; Hallén N; Chodick G; Bourvine L; Waner T; Karasik A
    Value Health Reg Issues; 2020 Sep; 22():83-92. PubMed ID: 32798839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA.
    Deitelzweig SB; Lovelace B; Christoph M; Lingohr-Smith M; Lin J; Fermann GJ
    Adv Ther; 2020 Sep; 37(9):3942-3953. PubMed ID: 32699994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource utilization and direct medical costs associated with index and recurrent
    Feuerstadt P; Stong L; Dahdal DN; Sacks N; Lang K; Nelson WW
    J Med Econ; 2020 Jun; 23(6):603-609. PubMed ID: 31999199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.